Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Other Working Capital Changes (2024 - 2025)

Connect Biopharma Holdings' Other Working Capital Changes history spans 2 years, with the latest figure at $1.8 million for Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 45.81% year-over-year to $1.8 million; the TTM value through Sep 2025 reached $5.3 million, changed N/A, while the annual FY2024 figure was -$14000.0, 99.62% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $1.8 million at Connect Biopharma Holdings, down from $2.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.2 million in Q2 2025 and bottomed at -$1.2 million in Q2 2024.